» Articles » PMID: 37099677

Late Recurrence of Atrial Fibrillation 5 Years After Catheter Ablation: Predictors and Outcome

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Atrial fibrillation (AF) is a chronic progressive disease that continuously recurs even after successful AF catheter ablation (AFCA). We explored the mechanism of long-term recurrence by comparing patient characteristics and redo-ablation findings.

Methods And Results: Among the 4248 patients who underwent a de novo AFCA and protocol-based rhythm follow-up at a single centre, we enrolled 1417 patients [71.7% male, aged 60.0 (52.0-67.0) years, 57.9% paroxysmal AF] who experienced clinical recurrences (CRs), and divided them according to the period of recurrence: within one year (n = 645), 1-2 years (n = 339), 2-5 years (n = 308), and after 5 years (CR>5 yr, n = 125). We also compared the redo-mapping and ablation outcomes of 198 patients. In patients with CR>5 yr, the proportion of paroxysmal AF was higher (P = 0.031); however, the left atrial (LA) volume (quantified by computed tomography, P = 0.003), LA voltage (P = 0.003), frequency of early recurrence (P < 0.001), and use of post-procedure anti-arrhythmic drugs (P < 0.001) were lower. A CR>5 yr was independently associated with a low LA volume [odds ratio (OR) 0.99 (0.98-1.00), P = 0.035], low LA voltage [OR 0.61 (0.38-0.94), P = 0.032], and lower early recurrence [OR 0.40 (0.23-0.67), P < 0.001]. Extra-pulmonary vein triggers during repeat procedures were significantly greater in patients with a CR>5 yr, despite no difference in the de novo protocol (P for trend 0.003). The rhythm outcomes of repeat ablation procedures did not differ according to the timing of the CR (log-rank P = 0.330).

Conclusions: Patients with a later CR exhibited a smaller LA volume, lower LA voltage, and higher extra-pulmonary vein triggers during the repeat procedure, suggesting AF progression.

Citing Articles

Ultrasound assessment of the association between left atrial remodeling and fibrosis in patients with valvular atrial fibrillation: a clinical investigation.

Xu T, Hu H, Zhu R, Hu W, Li X, Shen D BMC Cardiovasc Disord. 2025; 25(1):149.

PMID: 40045212 PMC: 11881324. DOI: 10.1186/s12872-025-04580-4.


Do extra-pulmonary triggers or autonomic neural activity affect rhythm control by anti-arrhythmic drugs in patients with post-ablation atrial fibrillation recurrence?.

Park H, Yu H, Kim D, Park J, Kim T, Uhm J Front Cardiovasc Med. 2024; 11:1426531.

PMID: 39434852 PMC: 11491320. DOI: 10.3389/fcvm.2024.1426531.


Repeat catheter ablation after very late recurrence of atrial fibrillation after pulmonary vein isolation.

Stauffer N, Knecht S, Badertscher P, Krisai P, Hennings E, Serban T Europace. 2024; 26(5).

PMID: 38607938 PMC: 11068271. DOI: 10.1093/europace/euae096.


Research on atrial fibrillation mechanisms and prediction of therapeutic prospects: focus on the autonomic nervous system upstream pathways.

Huang J, Wu B, Qin P, Cheng Y, Zhang Z, Chen Y Front Cardiovasc Med. 2023; 10:1270452.

PMID: 38028487 PMC: 10663310. DOI: 10.3389/fcvm.2023.1270452.

References
1.
Kirchhof P, Breithardt G, Camm A, Crijns H, Kuck K, Vardas P . Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial. Am Heart J. 2013; 166(3):442-8. DOI: 10.1016/j.ahj.2013.05.015. View

2.
Kim D, Hwang T, Kim M, Yu H, Kim T, Uhm J . Extra-Pulmonary Vein Triggers at and the Repeat Atrial Fibrillation Catheter Ablation. Front Cardiovasc Med. 2021; 8:759967. PMC: 8600078. DOI: 10.3389/fcvm.2021.759967. View

3.
Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu M, Rasmussen L . Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med. 2014; 128(5):509-18.e2. DOI: 10.1016/j.amjmed.2014.11.026. View

4.
January C, Samuel Wann L, Calkins H, Chen L, Cigarroa J, Cleveland Jr J . 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the.... J Am Coll Cardiol. 2019; 74(1):104-132. DOI: 10.1016/j.jacc.2019.01.011. View

5.
Fujimoto H, Doi N, Okayama S, Naito M, Kobori A, Kaitani K . Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction. Europace. 2021; 24(4):576-586. DOI: 10.1093/europace/euab201. View